Inovamed Ltd is one of Israel’s leading pharmaceutical companies, known for its consistent innovation, strategic agility, and global market excellence. Ranked among the top 3 companies in Israel for new product launches, Inovamed specialises in the development, licensing, and commercialisation of generic and branded formulations that improve access to high-quality medicines worldwide.
We operate with a simple mission:
Make healthcare affordable, accessible, and sustainable across borders.
With more than 100 SKUs launched and an active pipeline of 37+ new products, we bring speed, compliance, and strategic precision to every market we serve. Our in-house capabilities span Regulatory Affairs, Pharmacovigilance, Product Logistics, Licensing, and Marketing, allowing us to operate with unmatched responsiveness across Europe, the USA, China, Japan, South Korea, and emerging markets.
Our privately held structure enables fast, focused decision-making and long-term value creation for our partners. Whether you're a healthcare system, distributor, or biotech innovator, Inovamed is your partner of choice for strategic portfolio expansion and compliant market entry.
What Sets Us Apart:
●2nd Largest Portfolio of New Product Launches in Israel
●Trusted partner for highly regulated markets
●Full-spectrum capabilities: from registration to distribution
●Data-driven approach to market intelligence & product selection
●Commercial excellence through international licensing partnerships
●Consistent 20%+ annual growth and robust financial health
●Proven success with key launches like Fentamed™, Pioglitazone™, Bisoprolol™, and Stalevo™

INOVAMED LTD

Org chart

Teams

Offices